Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Open in API
Filings indexed 512 across all filing types
Latest filing 2017-11-01 Regulatory Filings
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2017-11-01 English
Capital/Financing Update 2017
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the SEC Division of Corporation Finance regarding a Registration Statement on Form S-1. It requests the effective date of the Form S-1 to be declared effective and mentions distribution of preliminary prospectuses. This is related to the process of securities registration and offering, specifically a capital raising event. The document is short (1269 characters) and is a correspondence related to a financing registration statement, not a full report or financial statement. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2017-11-01 English
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It includes a capitalization table and pro forma financial information related to a proposed securities offering and listing application on Nasdaq. The document does not contain full financial statements or comprehensive financial analysis typical of annual or interim reports. Instead, it provides specific event-driven information about capital structure changes and financing activities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length (8290 characters) and content confirm it is a substantive filing, not merely an announcement or certification.
2017-11-01 English
FWP Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed pursuant to the Securities Exchange Act of 1934. It includes a capitalization table and pro forma financial information related to a proposed securities offering and listing application on Nasdaq. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a transcript, proxy, or governance document. It is a regulatory filing providing material event disclosure about capital structure changes and offering details. The length (8431 characters) and content indicate it is a substantive regulatory announcement rather than a brief report publication announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2017-11-01 English
Capital/Financing Update 2017
Capital/Financing Update Classification · 95% confidence The document is a letter from NanoVibronix, Inc. to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-1. It references the Securities Act of 1933 and Rule 461, which are related to securities registration and offerings. The document is short (1043 characters) and is a formal request related to a capital raising process, not a financial report or earnings release. This fits the category of Capital/Financing Update (CAP), as it concerns the registration and timing of a securities offering.
2017-10-31 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 4 to Form S-1, a Registration Statement under the Securities Act of 1933, filed with the SEC. It includes detailed information about the securities being registered, offering prices, underwriting details, and legal disclaimers. The Form S-1 is used for initial public offerings or other securities registrations and is a capital raising document. The content focuses on the registration and offering of securities, including common stock, warrants, and convertible preferred stock, with no financial statements or earnings data presented. Therefore, this document is a Capital/Financing Update rather than an annual report, earnings release, or other types of filings.
2017-10-31 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.